Foxconn Pharma Invests 414M Yuan in Star Yao Kunze B Round Financing on May 26

GateNews
According to Foxconn Pharma's announcement on May 26, the company's subsidiary Foxconn Pharma Industrial invested 414 million yuan to participate in Star Yao Kunze's B round financing alongside other new investors and to acquire equity stakes held by affiliated entities Suzhou Fund and Tianjin Fund. Upon completion of the B round and equity transfer, Foxconn Pharma Industrial is expected to hold 20.8709% of Star Yao Kunze.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments